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Abstract 
Background: Persistent hypoxia stimulation, one of the most critical microenvironmental factors, accelerates the 
acquisition of epithelial–mesenchymal transition (EMT) phenotypes in lung cancer cells. Loss of phosphatase and 
tensin homologue deleted from chromosome 10 (PTEN) expression might accelerate the development of lung cancer 
in vivo. Recent studies suggest that tumor microenvironmental factors might modulate the PTEN activity though a 
decrease in total PTEN expression and an increase in phosphorylation of the PTEN C-terminus (p-PTEN), resulting in 
the acquisition of the EMT phenotypes. Nevertheless, it is not known whether persistent hypoxia can modulate PTEN 
phosphatase activity or whether hypoxia-induced EMT phenotypes are negatively regulated by the PTEN phos-
phatase activity. We aimed to investigate hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung 
cancers.
Methods: Western blotting was performed in five lung cancer cell lines to evaluate total PTEN expression levels and 
the PTEN activation. In a xenograft model of lung cancer cells with endogenous PTEN expression, the PTEN expres-
sion was evaluated by immunohistochemistry. To examine the effect of hypoxia on phenotypic alterations in lung 
cancer cells in vitro, the cells were cultured under hypoxia. The effect of unphosphorylated PTEN (PTEN4A) induction 
on hypoxia-induced EMT phenotypes was evaluated, by using a Dox-dependent gene expression system.
Results: Lung cancer cells involving the EMT phenotypes showed a decrease in total PTEN expression and an 
increase in p-PTEN. In a xenograft model, loss of PTEN expression was observed in the tumor lesions showing tissue 
hypoxia. Persistent hypoxia yielded an approximately eight-fold increase in the p-PTEN/PTEN ratio in vitro. PTEN4A 
did not affect stabilization of hypoxia-inducible factor 1α. PTEN4A blunted hypoxia-induced EMT via inhibition of 
β-catenin translocation into the cytoplasm and nucleus.
Conclusion: Our study strengthens the therapeutic possibility that compensatory induction of unphosphorylated 
PTEN may inhibit the acquisition of EMT phenotypes in lung cancer cells under persistent hypoxia.
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Background
The tumor microenvironment, which involves activa-
tion of various signal pathways, accelerates the acquisi-
tion of epithelial-mesenchymal transition (EMT) in lung 
cancers cells [1, 2]. Persistent hypoxia induces acquisition 
of EMT phenotypes, involving de novo EMT-related gene 
expression, such as twist, and the stabilization of hypoxia-
inducible factor 1α (HIF-1α), a significant transcriptional 
factors in hypoxia [3–7]. As a result, persistent hypoxia 
stimulation has been proposed as one of the most critical 
microenvironmental factors in the development of can-
cer and tissue fibrosis in vivo [5, 6, 8, 9]. The tumor sup-
pressor gene, phosphatase and tensin homologue deleted 
from chromosome 10 (PTEN), negatively regulates the 
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activation of various signaling pathways in the tumor 
microenvironment [10], but hyperactivation of these path-
ways is often observed in lung cancers [11–13]. Loss of 
PTEN expression might accelerate the development of lung 
cancer in vivo [14]. Meanwhile, recent studies suggest that 
phosphorylation of the PTEN C-terminus (p-PTEN) might 
directly induce a loss of PTEN activity [15, 16]. We recently 
showed that transforming growth factor β (TGFβ), one of 
another inducers of EMT, might lead to loss of PTEN activ-
ity through a decrease in total PTEN expression level and 
TGFβ-induced phosphorylation of its C-terminus in lung 
cancer cells [17]. Nevertheless, it is not known whether or 
not persistent hypoxia might modulate the PTEN phos-
phatase activity in lung cancers. Furthermore, whether 
hypoxia-induced EMT phenotypes are negatively regulated 
by unphosphorylated PTEN remains elusive.
Based on the knowledge that persistent hypoxia-
induced aberrant signaling pathway should be therapeu-
tic target for lung cancer [18, 19], we aimed to determine 
that persistent hypoxia can modulate the PTEN activity 
in lung cancers and that unphosphorylated PTEN can 
inhibit hypoxia-induced EMT.
Results
Effect of persistent hypoxia on total PTEN expression 
and phosphorylation of the C‑terminal tail in PTEN in lung 
cancers
To evaluate total PTEN expression levels and the 
p-PTEN/PTEN ratio in lung cancer cells, western blot-
ting was performed in the following five lung cancer cell 
lines: H441, H358, A549, H157 and H1299 [20]. Western 
blotting analysis showed that H1299 cells involving the 
EMT phenotypes (20), had lower PTEN expression level 
than H441 and H358 cells; as consequence the p-PTEN/
PTEN ratio was about threefold higher in H1299 cells 
than in H441 and H358 cells (Fig. 1a–c). These findings 
were supported by immunofluorescence images showing 
that PTEN protein was expressed in H358 cells, whereas 
H1299 cells showed low PTEN expression (Fig.  1d, e). 
To determine whether persistent hypoxia might modu-
late PTEN expression in lung cancer cells in  vivo, we 
examined the H358ON cells expressing GFP that had 
been grown in the flank of Dox-treated nude mice after 
administration of pimonidazole, which detects hypoxia 
via immunohistochemical staining [6, 17]. H–E stain-
ing showed tumor growth in the subcutaneous lesion 
of nude mice (Fig.  1f ). To detect tissue hypoxia in the 
tumor specimen in  vivo, immunostaining for pimoni-
dazole was performed (Fig. 1g). The tumor cells stained 
positive for intracellular pimonidazole, indicating that 
tissue hypoxia might be involved in the tumor lesions. 
Furthermore, to evaluate the association between tissue 
hypoxia and PTEN expression in tumor lesions in  vivo, 
immunostaining for PTEN in a serial section of the tumor 
sample was undertaken. Although the immunostaining 
showed no or little PTEN expression in the tumor lesions 
(Fig.  1h, i), positive staining for PTEN was observed in 
the subcutaneous tissue of nude mice (Fig. 1h, i).
Effect of persistent hypoxia on modulation of PTEN 
expression and EMT phenotypes in H358 cells in vitro
Next, to evaluate the effect of persistent hypoxia on modu-
lation of PTEN expression in lung cancers, H358 cells were 
treated under hypoxia in  vitro. Under persistent hypoxia 
stimulation, total PTEN levels decreased in a time-
dependent manner but p-PTEN levels remained steady in 
H358 cells, leading to an approximately eightfold increase 
in the p-PTEN/PTEN ratio 72 h after hypoxia stimulation 
(Fig. 2a, b). To determine whether persistent hypoxia can 
induce the acquisition of EMT phenotypes in H358 cells 
[6], western blotting analysis for fibronectin and E-cad-
herin was carried out [21–23], which demonstrated that 
hypoxia induced EMT phenotypes in H358 cells in a time-
dependent manner (Fig. 2c, d). Mounting evidence suggest 
that de novo expression of mesenchymal genes in epithe-
lial cells could be induced by translocation of β-catenin 
into the cytoplasm and the nucleus [21, 24]. Therefore, we 
determined hypoxia-stimulated translocation of β-catenin 
in lung cancer cells. Because many studies suggest that 
E-cadherin is one of the most important constituents of 
adherens junction on cell membrane [21, 25–27], dou-
ble immunostaing for β-catenin and E-cadherin was per-
formed and then the localization was evaluated by using 
confocal microscopy. The results suggested that β-catenin 
was co-localized with E-cadherin on the cell membrane in 
H358 cells cultured under normoxia (Fig.  2e, f ), but had 
translocated into the cytoplasm and the nucleus when the 
cells were cultured under hypoxia (Fig. 2e, f ).
Effect of unphosphorylated PTEN on hypoxia‑induced EMT 
in H358 cells
We previously demonstrated that unphosphorylated 
PTEN inhibits TGFβ-induced acquisition of the EMT 
phenotypes in lung cancer cells [17]. Nevertheless, 
whether or not phosphorylation of the PTEN C-ter-
minus might directly play a critical role in hypoxia-
induced EMT remains elusive. Here, therefore, we 
evaluated the effect of unphosphorylated PTEN on 
hypoxia-induced EMT phenotypes, by using a Dox-
dependent gene expression system (Fig.  3a). To evalu-
ate whether hypoxia-induced EMT can be modulated 
by Dox-induced GFP-PTEN4A expression, western 
blotting analysis for fibronectin and E-cadherin was 
carried out. There was no or little reduction in the 
fibronectin/E-cadherin ratio in GFP-expressing cells; 
however, de novo GFP-PTEN4A protein expression by 
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Dox yielded a significant decrease of about 88 % in the 
fibronectin/E-cadherin ratio (Fig.  3b, c). There was a 
limited repression in the fibronectin/E-cadherin ratio in 
GFP-WildPTEN-expressing cells (Fig. 3b, c); in particu-
lar, GFP-WildPTEN did not appear to repress hypoxia-
induced fibronectin expression.
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Effect of unphosphorylated PTEN on hypoxia‑induced 
stabilization of HIF‑1α expression, translocation 
of β‑catenin, and the EMT‑related gene twist expression 
in H358 cells
To investigate the molecular mechanisms underly-
ing PTEN4A activity, whether hypoxia-induced signal-
ing pathways could be modulated by GFP-PTEN4A was 
evaluated. A recent study demonstrated that HIF-1α 
expression directly regulates de novo EMT-related gene 
expression, causing an alteration in phenotype through 
EMT in a cancer metastasis model [5]. Here, Dox-
induced expression of de novo GFP, GFP-WildPTEN, or 
GFP-PTEN4A did not repress the increase in de novo 
HIF-1α expression in hypoxia-stimulated H358ON cells 
(Fig.  4a). Next, we used real-time PCR to investigate 
whether the inhibitory effect of unphosphorylated PTEN 
on hypoxia-induced acquisition of EMT phenotypes 
might depend on the altered expression of EMT-related 
genes (Fig. 4b). Our previous study showed that hypoxia 
stimulation induced the increasing levels of twist, but not 
snail, in H358 cells [6]. In the present study, although de 
novo GFP expression did not alter hypoxia-induced twist 
expression, the increasing twist mRNA levels in hypoxia-
stimulated H358ON cells expressing Dox-dependent 
GFP-WildPTEN and GFP-PTEN4A were repressed when 
Dox was added (Fig.  4b). Furthermore, we determined 
whether Dox-induced PTEN4A expression can modu-
late β-catenin translocation in hypoxia-stimulated lung 
cancer cells. Immunocytochemistry findings showed that 
translocation of β-catenin was not observed in H358ON 
cells expressing Dox-dependent GFP, GFP-WildPTEN, or 
GFP-PTEN4A when cultured under normoxia (Fig.  4c–
h). Although GFP or GFP-WildPTEN protein induced by 
Dox did not inhibit hypoxia-induced β-catenin translo-
cation into the cytoplasm and nucleus in H358ON cells 
(Fig.  4c–f), β-catenin translocation induced by hypoxia 
stimulation was completely inhibited by de novo GFP-
PTEN4A protein (Fig. 4g, h).
Discussion
Although PTEN mutations and deficiencies might be 
prevalent at the advanced tumor stage and in therapeu-
tic resistance in many types of human cancer [12, 28–30], 
lung cancers rarely show mutation of the PTEN gene 
[12, 31]. Furthermore, mounting evidence suggests that 
loss of the PTEN phosphatase activity via the increasing 
p-PTEN/PTEN ratio might be also crucial for many types 
of cancer to acquire malignant phenotypes [17, 27, 32, 33]. 
Therefore, we first evaluated total PTEN expression level 
and the phosphorylation level of PTEN in lung cancer 
cells, by assessing five lung cancer cell lines in which the 
EMT phenotypes had been previously analyzed [20]. The 
data suggested that, among the five lung cancer cell lines, 
those with low PTEN expression level and a high p-PTEN/
PTEN ratio showed a tendency to have a high degree of 
the EMT phenotypes [20]. In addition to the above find-
ings, the importance of the tumor microenvironment 
was suggested by recent studies [1, 2]. Because H358 cells 
were suitable for evaluating the underlying mechanisms, 
by which tumor microenvironment factors might induce 
EMT [6, 17, 20, 27], we utilized H358 cells for further 
experiments in the present study. Evidence of persistent 
hypoxia has been shown in tumor implant models and 
pulmonary fibrosis by several reliable approaches based 
on the detection of hypoxia-related molecules, such as 
pimonidazole [6, 34, 35]. Indeed, our immunohistochemi-
cal findings in vivo suggested that tumor lesions with per-
sistent hypoxia might show no or little PTEN expression. 
Because H358ON cells retain endogenous PTEN expres-
sion before inoculation into mice (Fig.  1), the decreased 
expression of PTEN observed in cancer cells indicates that 
persistent tissue hypoxia might modulate PTEN expres-
sion in vivo. It should be noted that phosphorylated PTEN 
expression was not detected in tumor specimens, pos-
sibly owing to our use of an antibody that is not recom-
mended for immunohistochemistry staining. Although the 
acquisition of EMT phenotypes is modulated by persistent 
(See figure on previous page.) 
Fig. 1 Total PTEN levels and phosphorylation levels of the PTEN C-terminus in lung cancer cells. The levels of total PTEN and p-PTEN expression 
were evaluated in five lung cancer cell lines. a Cell extracts were harvested for the analysis of p-PTEN, PTEN, and β-actin by western blotting. Equal 
amounts (20 μg) of protein were loaded for analysis. The ratio of total PTEN protein to β-actin, b and p-PTEN to total PTEN protein, c is presented as 
an intensity level relative to that in H441 cells. A representative blot is shown from three independent experiments. Asterisk indicates p < 0.05. (b, c), 
d Immunostaining for PTEN (green) was performed in H1299 (left) and H358 (right) cells. Nuclear staining was performed by Hoechst33342 (blue). 
Results are representative of three independent experiments. All images shown are × 200 magnification. e NIS-Elements AR software was used to 
compare the intensity level of PTEN expression between H1299 (left panels in d) and H358 (right panels in d) cells, compensated by cell numbers, 
which were counted by Hoechst33342 staining. Data represent the mean ± SE of two independent experiments. Asterisk indicates p < 0.05. To 
evaluate whether persistent hypoxia might modulate PTEN expression in lung cancer cells in vivo, we examined the tumor sections from Dox-
treated nude mice at day 28 after inoculation with H358ON cells carrying GFP. f H–E staining was performed on tumor tissues. g Immunostaining 
for pimonidazole as a hypoxia marker was performed on a serial section of tumor tissues. An arrow indicates the cells positive for pimonidazole. h 
Control immunostaining for PTEN on a serial section of tumor samples is shown. i Immunostaining for PTEN was also performed on the serial section 
of tumor samples. An arrow indicates the cells positive for PTEN. Representative tumor sections are shown from three independent experiments.  
f–i All images shown are ×200 magnification
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hypoxia [3–7], persistent hypoxia induces a decrease in 
total PTEN expression and increases the p-PTEN/PTEN 
ratio over time in H358 cells incubated under hypoxia. 
Our in vitro data suggested that persistent hypoxia mark-
edly repressed the expression of total PTEN expression in 
a time-dependent manner, whereas phosphorylated PTEN 
levels remained persistent even after hypoxia stimula-
tion, resulting in an approximately eightfold increase in 
the p-PTEN/PTEN ratio in  vitro [36–38]. These findings 
indicate that modulation of total PTEN expression and 
the increasing p-PTEN/PTEN ratio might be induced 
not only by TGFβ activation [17] but also by persistent 
hypoxia stimulation in lung cancer cells. Mounting evi-
dence show that β-catenin is located on the cell membrane 
via E-cadherin complexes [21, 25, 26]. We previously dem-
onstrated that although β-catenin and E-cadherin were 
Fig. 2 Hypoxia-induced modulation of PTEN expression and EMT in H358 cells. a Cell extracts were analyzed for the levels of total and phospho-
rylated PTEN at the indicated time. A blot is representative of three independent experiments. b The ratio of p-PTEN to total PTEN is presented as 
an intensity level relative to that in H358 naïve cells at 0 min. Data were shown as the mean ± standard error (SE). The experiment was performed 
three times with similar results. Asterisk indicates p < 0.05. c Western blotting analysis for fibronectin and E-cadherin at the indicated time points was 
carried out. A blot is representative of three independent experiments. d The ratio of fibronectin to E-cadherin (F/E ratio) was evaluated, compared 
with that in cells treated under hypoxia at 0 min (bottom). Asterisk indicates p < 0.05. e, f By using confocal laser scanning microscopy and imaging 
software, we evaluated the fluorescence intensities of β-catenin (red) and E-cadherin (green) in the cells under normoxia or hypoxia. Hoechst33342 
(blue) was utilized for nuclear staining. The left and right images in e shows cells cultured under normoxia and hypoxia, respectively. The upper and 
lower panels in f plot the fluorescence intensity of β-catenin red, E-cadherin green, and nucleus blue over a cross-section of cells cultured under 
normoxia and hypoxia, respectively. Data are representative of at least three independent experiments
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co-localized on the cell membrane when the cells were 
not treated with TGFβ, TGFβ might induce translocation 
of β-catenin from the cell membrane to the cytoplasm 
and nucleus [27]. Taken together with the previous studies 
[21, 25], double immunostaining for β-catenin and E-cad-
herin suggested that persistent hypoxia might also induce 
translocation of β-catenin from the cell membrane to the 
cytoplasm and nucleus resulting in induction of mesen-
chymal gene expression. Therefore, a therapeutic strategy 
to comprehensively regulate various factors derived from 
tumor microenvironment might be warranted. Never-
theless, whether or not hypoxia-induced EMT might be 
directly affected by the increasing phosphorylation levels 
of the PTEN C-terminus has not been fully evaluated. In 
the present study, compensatory induction of unphos-
phorylated PTEN blunted hypoxia-induced EMT in lung 
cancer cells. Although persistent hypoxia-induced HIF-1α 
stabilization can cause the acquisition of malignant phe-
notypes [5, 7], PTEN4A did not appear to modulate 
hypoxia-induced HIF-1α stabilization, indicating that the 
compensatory induction of PTEN4A inhibited the acquisi-
tion of hypoxia-induced EMT phenotypes by mechanisms 
other than HIF-1α stabilization [39]. Although hypoxia 
is known to induce de novo twist expression [5, 6], our 
data suggested that compensatory induction of either 
PTEN4A or WildPTEN induced the decreasing levels 
Fig. 3 Effect of modulating phosphorylation sites in the PTEN C-terminuson hypoxia-induced EMT in H358 cells. a The indicated cells were treated 
with vehicle or Dox for 24 h before hypoxia stimulation. And then, the cells were cultured under normoxia or hypoxia for a further 24 h in the 
absence or presence of Dox. Western blotting analysis for total PTEN (top) and p-PTEN (bottom) was carried out. A blot is representative of three 
independent experiments (GFP, left; GFP-WildPTEN, middle; GFPPTEN4A, right). b Western blotting analysis for fibronectin and E-cadherin in the 
indicated cells cultured under normoxia or hypoxia for 48 h was carried out. A blot is representative of three independent experiments. c F/E ratio in 
the treated cells was compared with that in cells treated with vehicle in the absence of Dox. Asterisk indicates p < 0.05
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of hypoxia-induced twist gene. De novo expressed GFP-
WildPTEN protein decreased the fibronectin/E-cadherin 
ratio and expression of twist in the cells under persistent 
hypoxia. Meanwhile, it did not block hypoxia-induced 
β-catenin translocation from the cell membrane into 
the cytoplasm and nucleus. A recent study suggests that 
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fibronectin transcription is induced by β-catenin translo-
cation from E-cadherin complexes at the cell membrane 
into the cytoplasm and nucleus [21]. Indeed, WildPTEN 
did not appear to repress hypoxia-induced fibronectin 
expression, whereas repression of hypoxia-induced E-cad-
herin was restored by induction of WildPTEN. PTEN 
binds E-cadherin complex via the PDZ binding domain 
in the PTEN C-terminus [40]. Previous studies sug-
gested that total PTEN expression levels might affect the 
response to WildPTEN transduction in glioma cells [28–
30]. In the present study, we showed that PTEN protein 
was abundantly expressed in H358 cells under normoxia, 
whereas persistent hypoxia induced the repression of total 
PTEN expression in H358 cells to the same degree as that 
in H1299 cells. Taken together, compensatory induction 
of WildPTEN might restore the repression of E-cadherin 
expression in hypoxia-induced H358 cells showing lit-
tle expression of PTEN. Thus, exogenous administration 
of the PTEN gene might be hopeful for treatment of lung 
cancer under persistent hypoxia. It should be noted that de 
novo GFP-PTEN4A protein expression showed an approx-
imately 40  % greater potential to block hypoxia-induced 
EMT in comparison with de novo GFP-WildPTEN pro-
tein expression. We demonstrated that unphosphorylated 
PTEN, but not WildPTEN, inhibits TGFβ-induced EMT 
[17]. Research into the role of unphosphorylated PTEN 
in EMT induced by tumor microenvironmental factors 
remains important [27].
In summary, our studies strengthen the therapeutic 
possibility that compensatory induction of unphospho-
rylated PTEN may inhibit the acquisition of EMT phe-
notypes in lung cancers under tissue microenvironments 
involving persistent hypoxia stimulation.
Methods
Materials
All antibodies used in our experiments were purchased 
from the commercial companies as follow: monoclonal 
mouse anti-hypoxia-inducible factor 1α (HIF-1α) anti-
body was from Novus biologics (Littleton, CO); mono-
clonal mouse anti-PTEN antibody (clone 6H2.1) was 
from Cascade Bioscience (Winchester, UK); anti-β-
catenin antibody and purified and fluorescein isothio-
cyanate (FITC)-conjugated mouse anti-E-cadherin 
antibody were from BD Biosciences (San Diego, CA); 
purified anti-fibronectin antibody was from Santa Cruz 
Biotechnology, Inc (Santa Cruz, CA); streptavidin (SAv)-
Alexa 594 (SAv-594)-conjugated and SAv-Alexa 488 
(SAv-488)-conjugated anti mouse antibody was from Inv-
itrogen Life Technologies (Carlsbad, CA); purified rabbit 
anti-phospho-PTEN (Ser380/Thr382/Thr383) antibody 
was from Cell Signaling Technology (Boston, MA); 
Affinity-isolated rabbit anti-actin antibody was from 
Sigma-Aldrich (St. Louis, MO). Hoechst33342 was from 
Dojindo (Kumamoto, Japan). The Hypoxyprobe-1 plus 
kit was purchased from Hypoxyprobe, Inc. (Burlington, 
MA). Horseradish peroxidase (HRP)-conjugated anti-
mouse antibody, 3, 3′-diaminobenzidine (DAB) Substrate 
Kit, and Hematoxylin QS were from Vector Laboratories 
(Burlingame, CA). PhosSTOP was from Roche Applied 
Science (Mannheim, Germany). Can Get Signal was also 
purchased from Toyobo Co. (Tokyo, Japan). Doxycycline 
(Dox) was from Clontech (Mountain View, CA). pTRE-
Tight vector and pTet-On Advanced were from Clontech 
(Mountain View, CA).
Vectors and gene transfection
A Dox-dependent gene expression system was applied to 
H358 cells, a human lung cancer cell line, carrying pTet-
On Advanced (H358ON) [17]. The H358ON cells that 
were generated contained GFP in the pTRE-Tight vec-
tor (GFP), GFP-PTEN in the pTRE-Tight vector (GFP-
WildPTEN), or GFP-PTEN with a four-Ala substitution 
(S380A, T382A, T383A, and S385A) on the C-termi-
nal tail in PTEN (PTEN4A) in the pTRE-Tight vector 
(GFP-PTEN4A).
(See figure on previous page.) 
Fig. 4 Effect of unphosphorylated PTEN on hypoxia-induced stabilization of HIF-1α expression, translocation of β-catenin, and the EMT-related gene 
twist expression in H358 cells. a The indicated cells were treated with vehicle or Dox for 24 h before hypoxia stimulation. And then, the cells were 
cultured under normoxia or hypoxia for a further 6 h in the absence or presence of Dox. Western blotting analysis for f HIF-1α was carried out. A blot 
is representative of three independent experiments (GFP, left; GFP-WildPTEN, middle; GFPPTEN4A, right). The ratio of HIF-1α to β-actin was compared 
with that in the cells cultured under normoxia in the absence of Dox. *p < 0.05 NS not significant. b The indicated cells were treated with vehicle or 
Dox for 24 h before hypoxia stimulation. And then, the cells were cultured under normoxia or hypoxia for a further 24 h in the absence or presence 
of Dox. The expression levels of twist mRNA were analyzed by using real-time PCR and normalized to GAPDH mRNA (GFP, left; GFP-WildPTEN, middle; 
GFPPTEN4A, right). The relative twist expressions were compared with that in cells treated under normoxia. Data represent the mean ± standard 
error of the mean (SEM) from three independent experiments. *p < 0.05, NS not significant. c–h The indicated cells were treated with vehicle or Dox 
for 24 h before hypoxia stimulation. And then, the cells were cultured under normoxia or hypoxia for a further 24 h in the absence or presence of 
Dox. The intensity of fluorescence of β-catenin and E-cadherin was evaluated in H358ON cells with Dox-dependent GFP (c, d), GFP-WildPTEN (e, f) 
or GFP-PTEN4A (g, h) was evaluated. The left and right images in c, e, g show cells under normoxia and hypoxia, respectively. The upper and lower 
panels in d, f, h plot the fluorescence intensity of β-catenin (red), E-cadherin (green), and nucleus (blue) over a cross section of cells under normoxia 
and hypoxia, respectively. Data are representative of at least three independent experiments
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Cells
Human lung cell lines H441, H358, A549, H157 and 
H1299, were maintained in RPMI medium as previously 
described [20]. To examine the effect of hypoxia on phe-
notypic alterations in lung alveolar cell lines in vitro, the 
cells were cultured under hypoxia (1 % concentration of 
oxygen; 1 % O2) for the indicated periods using a hypoxic 
chamber (Wakenyaku Co. Ltd., Tokyo, Japan) for the 
indicated periods. For immunocytochemistry, some cells 
were cultured in an 8-well Lab-Tek Chamber Slide Sys-
tem (Nalge Nunc International, Naperville, IL). Pimoni-
dazole hydrochloride at final concentration of 150  μM 
was added 90 min before immunostaining for pimonida-
zole [6].
Real‑time PCR
We performed real-time PCR, by using a TaqMan ABI 
7300 Sequence Detection System (PE Applied Biosys-
tems, Foster City, CA). The following oligonucleotide 
primers and probe were used: twist (twist1: NM_000474) 
sense (5′-CCAGCTATGTGGCTCACGAG-3′) and anti-
sense (5′-CTAGTGGGACGCGGACATGG-3′), internal 
fluorescence-labeled probe (FAM) (5′-CCTCCATCCTC 
CAGACCGAGAAGGCG-3′) [20]. The twist mRNA 
expression levels were normalized to the glyceralde-
hydes-3-phophate dehydrogenase (GAPDH) mRNAs sig-
nal [41].
Western blotting analysis
Protein immunodetection was performed by electro-
phoretic transfer of SDS-PAGE, separation of proteins 
on nitrocellulose, incubation with primary antiboby, fol-
lowed by the appropriate HRP-conjugate second anti-
body, and chemiluminescent second-step detection using 
ECL Plus (GE Healthcare Bio-Sciences Corp; Piscataway, 
NJ) [17]. The amount of protein on the immunoblots was 
quantified by the image software Quantity One (BioRad 
Laboratories, Philadelphia, PA) [20].
Immunocytochemistry and immunehistochemistry
Immunocytochemistry and immunohistochemistry was 
done as previously described [9, 42, 43]. Immunofluo-
rescent staining for PTEN in  vitro was performed for 
H358 cells and H1299 cells and SAv-488-conjugated anti 
mouse antibody was utilized to visualize antibody bind-
ing. Nuclear staining was performed by Hoechst33342. 
To determine the impact of PTEN4A transduction on 
hypoxia-induced β-catenin translocation, double immu-
nostaining for β-catenin and E-cadherin was done for 
H358 cells and H358ON cells with Dox-dependent GFP, 
GFP-WildPTEN, or GFP-PTEN4A according the pre-
vious procedure [27]. We determined distribution of 
β-catenin by using confocal laser scanning microscopy 
(TiEA1R; Nikon Instech Co., Tokyo, Japan). Imaging 
software (NIS-Elements AR; Nikon Instech Co., Tokyo, 
Japan) was utilized for the intensity of β-catenin fluo-
rescence. To evaluate the fluorescence, intensities over a 
random cross section of the cells were plotted [27]. Meas-
urement of fluorescence intensity in the nucleus and the 
cytoplasm was performed by evaluation of a minimum of 
five randomly selected high-power fields per sample [44]. 
Immunostaining for pimonidazole in vivo was performed 
by following the manufacturer’s instructions with minor 
modifications [6]. To evaluate PTEN expression in the 
tumor specimens in vivo, a DAB Substrate Kit was used 
to visualize antibody binding [42]. Sections were counter-
stained with Hematoxylin QS.
Mouse tumor implantation in vivo
H358ON cells (3 × 106) expressing Dox-dependent GFP 
were inoculated subcutaneously into the flank of 6-week-
old female nude mice. The treated mice were maintained 
on water containing Dox at a final concentration of 2 mg/
ml [17].
Statistical analysis
Non-normally distributed results were analyzed by using 
the Mann–Whitney test for comparison between any 
two groups. Furthermore, they were analyzed by non-
parametric equivalents of analysis of variance (ANOVA) 
for multiple comparisons. A p value of less than 0.05 was 
considered statistically significant.
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